- Latest available (Revised)
- Point in Time (11/04/2006)
- Original (As adopted by EU)
Commission Directive 2001/15/EC of 15 February 2001 on substances that may be added for specific nutritional purposes in foods for particular nutritional uses (Text with EEA relevance) (repealed)
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
Version Superseded: 31/12/2009
EU Directives are published on this site to aid cross referencing from UK legislation. Since IP completion day (31 December 2020 11.00 p.m.) no amendments have been applied to this version.
For the purpose of this table:
‘FSMP’ means foods for particular nutritional uses intended for special medical purposes,
‘All FPNU’ means dietary foods for particular nutritional uses including FSMPs but excluding infant formulae, follow-on formulae, processed cereal-based foods and baby foods intended for infants and young children.
Substance | Condition of use | |
---|---|---|
All FPNU | FSMP | |
Category 1.Vitamins | ||
VITAMIN A | ||
— retinol | x | |
— retinyl acetate | x | |
— retinyl palmitate | x | |
— beta-carotene | x | |
VITAMIN D | ||
— cholecalciferol | x | |
— ergocalciferol | x | |
VITAMIN E | ||
— D-alpha-tocopherol | x | |
— DL-alpha-tocopherol | x | |
— D-alpha-tocopheryl acetate | x | |
— DL-alpha-tocopheryl acetate | x | |
— D-alpha-tocopheryl acid succinate | x | |
VITAMIN K | ||
— phylloquinone (phytomenadione) | x | |
VITAMIN B1 | ||
— thiamin hydrochloride | x | |
— thiamin mononitrate | x | |
VITAMIN B2 | ||
— riboflavin | x | |
— riboflavin 5'-phosphate, sodium | x | |
NIACIN | ||
— nicotinic acid | x | |
— nicotinamide | x | |
PANTOTHENIC ACID | ||
— D-pantothenate, calcium | x | |
— D-pantothenate, sodium | x | |
— dexpanthenol | x | |
VITAMIN B6 | ||
— pyridoxine hydrochloride | x | |
— pyridoxine 5'-phosphate | x | |
— pyridoxine dipalmitate | x | |
[F1FOLATE] | ||
— pteroylmonoglutamic acid | x | |
[F2—calcium-L-methylfolate | x | ] |
VITAMIN B12 | ||
— cyanocobalamin | x | |
— hydroxocobalamin | x | |
BIOTIN | ||
— D-biotin | x | |
VITAMIN C | ||
— L-ascorbic acid | x | |
— sodium-L-ascorbate | x | |
— calcium-L-ascorbate | x | |
— potassium-L-ascorbate | x | |
— L-ascorbyl 6-palmitate | x | |
Category 2. Minerals | ||
CALCIUM | ||
— carbonate | x | |
— chloride | x | |
— salts of citric acid | x | |
— gluconate | x | |
— glycerophosphate | x | |
— lactate | x | |
— salts of orthophosphoric acid | x | |
— hydroxide | x | |
— oxide | x | |
[F3— sulphate | x | ] |
MAGNESIUM | ||
— acetate | x | |
— carbonate | x | |
— chloride | x | |
— salts of citric acid | x | |
— gluconate | x | |
— glycerophosphate | x | |
— salts of orthophosphoric acid | x | |
— lactate | x | |
— hydroxide | x | |
— oxide | x | |
— sulphate | x | |
[F2— magnesium L-aspartate | x] | |
IRON | ||
— ferrous carbonate | x | |
— ferrous citrate | x | |
— ferric ammonium citrate | x | |
— ferrous gluconate | x | |
— ferrous fumarate | x | |
— ferric sodium diphosphate | x | |
— ferrous lactate | x | |
— ferrous sulphate | x | |
— ferric diphosphate (ferric pyrophosphate) | x | |
— ferric saccharate | x | |
— elemental iron (carbonyl + electrolytic + hydrogen reduced) | x | |
[F2— ferrous bisglycinate | x | ] |
COPPER | ||
— cupric carbonate | x | |
— cupric citrate | x | |
— cupric gluconate | x | |
— cupric sulphate | x | |
— copper lysine complex | x | |
IODINE | ||
— potassium iodide | x | |
— potassium iodate | x | |
— sodium iodide | x | |
— sodium iodate | x | |
ZINC | ||
— acetate | x | |
— chloride | x | |
— citrate | x | |
— gluconate | x | |
— lactate | x | |
— oxide | x | |
— carbonate | x | |
— sulphate | x | |
MANGANESE | ||
— carbonate | x | |
— chloride | x | |
— citrate | x | |
— gluconate | x | |
— glycerophosphate | x | |
— sulphate | x | |
SODIUM | ||
— bicarbonate | x | |
— carbonate | x | |
— chloride | x | |
— citrate | x | |
— gluconate | x | |
— lactate | x | |
— hydroxide | x | |
— salts of orthophosphoric acid | x | |
POTASSIUM | ||
— bicarbonate | x | |
— carbonate | x | |
— chloride | x | |
— citrate | x | |
— gluconate | x | |
— glycerophosphate | x | |
— lactate | x | |
— hydroxide | x | |
— salts of orthophosphoric acid | x | |
SELENIUM | ||
— sodium selenate | x | |
— sodium hydrogen selentine | x | |
— sodium selenite | x | |
CHROMIUM (III) and their hexahydrates | ||
— chloride | x | |
— sulphate | x | |
MOLYBDENUM (VI) | ||
— ammonium molybdate | x | |
— sodium molybdate | x | |
FLUORINE | ||
— potassium fluoride | x | |
— sodium fluoride | x | |
Category 3. Amino acids | ||
— L-alanine | x | |
— L-arginine | x | |
— L-aspartic acid | x | |
— L-citrulline | x | |
— L-cysteine | x | |
— Cystine | x | |
— L-histidine | x | |
— L-glutamic acid | x | |
— L-glutamine | x | |
[X1— glycine | x | |
— L-isoleucine | x | ] |
— L-leucine | x | |
— L-lysine | x | |
— L-lysine acetate | x | |
— L-methionine | x | |
— L-ornithine | x | |
— L-phenylalanine | x | |
— L-proline | x | |
— L-threonine | x | |
— L-tryptophan | x | |
— L-tyrosine | x | |
— L-valine | x | |
[F3>— L-serine | x | |
— L-arginine-L-aspartate | x | |
— L-lysine-L-aspartate | x | |
— L-lysine-L-glutamate | x | |
— N-acetyl-L-cysteine | x | |
— N-acetyl-L-methionine | x in products intended for persons over 1 year of age] | |
For animo acids, as far as applicable, also the sodium, potassium calcium and magnesium salts as well as their hydrochlorides may be used | ||
Category 4. Carnitine and taurine | ||
— L-carnitine | x | |
— L-carnitine hydrochloride | x | |
— taurine | x | |
[F3— L-carnitine-L-tartrate | x | ] |
Category 5. Nucleotides | ||
— adenosine 5'-phosphoric acid (AMP) | x | |
— sodium salts of AMP | x | |
— cytidine 5'-monophosphoric acid (CMP) | x | |
— sodium salts of CMP | x | |
— guanosine 5'-phosphoric acid (GMP) | x | |
— sodium salts of GMP | x | |
— insosine 5'-phosphoric acid (IMP) | x | |
— sodim salts of IMP | x | |
— uridine 5'-phosphoric acid (UMP) | x | |
— sodium salts of UMP | x | |
Category 6. Choline and inositol | ||
— choline | x | |
— choline chloride | x | |
— choline bitartrate | x | |
— choline citrate | x | |
— inositol | x |
Editorial Information
X1 Substituted by Corrigendum to Commission Directive 2001/15/EC of 15 February 2001 on substances that may be added for specific nutritional purposes in foods for particular nutritional uses (Official Journal of the European Communities L 52 of 22 February 2001).
Textual Amendments
F1 Substituted by Commission Directive 2006/34/EC of 21 March 2006 amending the Annex to Directive 2001/15/EC as regards the inclusion of certain substances (Text with EEA relevance).
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: